Compounds > 2,3-bis(3'-hydroxybenzyl)butyrolactone
Page last updated: 2024-09-02

2,3-bis(3'-hydroxybenzyl)butyrolactone and 9,10-dimethyl-1,2-benzanthracene

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with 9,10-dimethyl-1,2-benzanthracene in 4 studies

Compound Research Comparison

Studies
(2,3-bis(3'-hydroxybenzyl)butyrolactone)		Trials
(2,3-bis(3'-hydroxybenzyl)butyrolactone)		Recent Studies (post-2010)
(2,3-bis(3'-hydroxybenzyl)butyrolactone)		Studies
(9,10-dimethyl-1,2-benzanthracene)		Trials
(9,10-dimethyl-1,2-benzanthracene)		Recent Studies (post-2010) (9,10-dimethyl-1,2-benzanthracene)
319321246,01010772

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collan, YU; Eckerman, C; Huovinen, R; Mäkelä, SI; Needham, L; Saarinen, NM; Santti, R; Valentín-Blasini, L; Wärri, A1
Ammälä, J; Collan, YU; Eckerman, C; Huovinen, R; Lehtilä, R; Mäkelä, SI; Saarinen, NM; Santti, RS; Sjöholm, R; Valentín-Blasini, L; Wärri, A1
Hurmerinta, TT; Mäkelä, SI; Penttinen, PE; Saarinen, NM; Smeds, AI1
Airio, M; Dings, RP; Mäkelä, S; Saarinen, NM; Smeds, AI; Wärri, A1

Other Studies

4 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and 9,10-dimethyl-1,2-benzanthracene

ArticleYear
Uptake and metabolism of hydroxymatairesinol in relation to its anticarcinogenicity in DMBA-induced rat mammary carcinoma model.
    Nutrition and cancer, 2001, Volume: 41, Issue:1-2

    Topics: 4-Butyrolactone; 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Anticarcinogenic Agents; Diet; Estrogens, Non-Steroidal; Female; Isoflavones; Lignans; Mammary Neoplasms, Experimental; Organ Size; Phytoestrogens; Plant Preparations; Rats; Rats, Sprague-Dawley; Uterus

2001
Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat.
    Molecular cancer therapeutics, 2002, Volume: 1, Issue:10

    Topics: 4-Butyrolactone; 9,10-Dimethyl-1,2-benzanthracene; Animals; Aromatase Inhibitors; Carcinogens; Cell Division; Enzyme Inhibitors; Estrogens; Estrogens, Non-Steroidal; Female; Isoflavones; Lignans; Mammary Neoplasms, Animal; Models, Chemical; Organ Size; Phytoestrogens; Plant Preparations; Rats; Rats, Sprague-Dawley; Time Factors; Uterus

2002
Structural determinants of plant lignans for growth of mammary tumors and hormonal responses in vivo.
    The Journal of steroid biochemistry and molecular biology, 2005, Volume: 93, Issue:2-5

    Topics: 4-Butyrolactone; 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Female; Furans; Lignans; Male; Mammary Neoplasms, Experimental; Molecular Structure; Organ Size; Phytotherapy; Plants; Prostate; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Uterus

2005
Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.
    International journal of cancer, 2008, Sep-01, Volume: 123, Issue:5

    Topics: 4-Butyrolactone; 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Butylene Glycols; Carcinogens; Cell Proliferation; Dietary Supplements; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Furans; Gene Expression Regulation, Neoplastic; Humans; Lignans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Ovariectomy; Phytoestrogens; Rats; Receptors, Progesterone; Transplantation, Heterologous

2008